Professional Documents
Culture Documents
24, 2016
PUBLISHED BY ELSEVIER
Letters
hospital discharges in the United States (2). Pre- Mild LD 6 (0.2) 0 (0.0) 0.74
Diabetes 262 (9.8) 5 (10.4) 0.88
existing medical conditions were identified using
Diabetes þ 31 (1.2) 0 (0.0) 0.45
the Deyo modification of the Charlson comorbidity complications
index (3). Two commonly used bleeding risk scores HP/PAPL 29 (1.1) 11 (22.9) <0.001
used for assessing bleeding risk in patients on anti- RD 139 (5.2) 3 (6.3) 0.74
coagulation—the HASBLED (4), and ATRIA (5)—were Cancer 128 (4.8) 3 (6.3) 0.64
assessed to identify ability to accurately identify risk Moderate/severe LD 4 (0.1) 0 (0.0) 0.79
Metastatic cancer 77 (2.9) 1 (2.1) 0.74
of ICH in PE patients receiving thrombolytic therapy.
AIDS 4 (0.1) 0 (0.0) 0.79
The individual components of the HAS-BLED score
Shock 160 (6.0) 1 (2.1) 0.26
were identified from administrative codes: hyper-
tension (ICD-9 codes 401, 405), abnormal renal func- Values are median (interquartile range) or n (%).
AIDS ¼ acquired immune deficiency syndrome; AMI ¼ acute myocardial infarc-
tion (codes 585), abnormal liver function (codes 571,
tion; COPD ¼ chronic obstructive pulmonary disease; CEVD ¼ cerebrovascular
573.9), stroke (438), bleeding (459), coagulopathy disease; HP ¼ hemiplegia; ICH ¼ intracranial hemorrhage; LD ¼ liver disease;
PAPL ¼ paraplegia; PE ¼ pulmonary embolism; PUD ¼ peptic ulcer; PVD ¼
(286.9), elderly (age >65 years), and alcohol (303.9)/ peripheral vascular disease; RD ¼ renal disease.
drug use (304.9). Similar methodology was used to
JACC VOL. 67, NO. 24, 2016 Letters 2905
JUNE 21, 2016:2904–11